308 related articles for article (PubMed ID: 36214901)
1. The international consensus classification of mastocytosis and related entities.
Leguit RJ; Wang SA; George TI; Tzankov A; Orazi A
Virchows Arch; 2023 Jan; 482(1):99-112. PubMed ID: 36214901
[TBL] [Abstract][Full Text] [Related]
2. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
[TBL] [Abstract][Full Text] [Related]
4. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.
Azaña JM; Torrelo A; Matito A
Actas Dermosifiliogr; 2016; 107(1):15-22. PubMed ID: 26525106
[TBL] [Abstract][Full Text] [Related]
5. [Mastocytosis and eosinophilic leukemia: diagnostics and classification].
Sotlar K; Valent P; Horny HP
Pathologe; 2012 Nov; 33(6):539-52. PubMed ID: 23085697
[TBL] [Abstract][Full Text] [Related]
6. The Spectrum of Aggressive Mastocytosis: A Workshop Report and Literature Review.
Leguit R; Hebeda K; Kremer M; van der Walt J; Gianelli U; Tzankov A; Orazi A
Pathobiology; 2020; 87(1):2-19. PubMed ID: 31802761
[TBL] [Abstract][Full Text] [Related]
7. Review and Updates on Systemic Mastocytosis and Related Entities.
Li JY; Ryder CB; Zhang H; Cockey SG; Hyjek E; Moscinski LC; Sagatys E; Song J
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067330
[TBL] [Abstract][Full Text] [Related]
8. Biology, classification and treatment of human mastocytosis.
Valent P
Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423
[TBL] [Abstract][Full Text] [Related]
9. Mast cell leukemia.
Georgin-Lavialle S; Lhermitte L; Dubreuil P; Chandesris MO; Hermine O; Damaj G
Blood; 2013 Feb; 121(8):1285-95. PubMed ID: 23243287
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive mastocytosis data analysis from a single center.
Tiryaki TO; Özkan SG; Erdem S; Aday AD; Hindilerden İY; Gelincik A; Baykal C; Yegen G; Doğan İÖ; Büyükbabani N; Nalçacı M; Yavuz AS
BMC Cancer; 2023 Jan; 23(1):82. PubMed ID: 36694141
[TBL] [Abstract][Full Text] [Related]
11. Systemic mastocytosis.
Ozdemir D; Dagdelen S; Erbas T
Am J Med Sci; 2011 Nov; 342(5):409-15. PubMed ID: 21629042
[TBL] [Abstract][Full Text] [Related]
12. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
13. Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis.
Aberer E; Sperr WR; Bretterklieber A; Avian A; Hadzijusufovic E; Kluin-Nelemans HC; Oude Elberink H; van Anrooij B; Niedoszytko M; Lange M; Górska A; Elena C; Brazzelli V; Belloni Fortina A; Caroppo F; Hartmann K; Illerhaus A; Reiter A; Jawhar M; Bonadonna P; Zanotti R; Triggiani M; Parente R; Gotlib J; Doubek M; von Bubnoff N; Fuchs D; Sabato V; Brockow K; Jäkel N; Panse J; Valent P
J Invest Dermatol; 2021 Jul; 141(7):1719-1727. PubMed ID: 33581142
[TBL] [Abstract][Full Text] [Related]
14. Mast Cell Burden in a Patient With Cutaneous Disease.
Awosika O; Eleryan M; Rengifo-Pardo M; Ehrlich A
J Drugs Dermatol; 2017 Dec; 16(12):1285-1287. PubMed ID: 29240865
[TBL] [Abstract][Full Text] [Related]
15. Advanced systemic mastocytosis-Revised classification, new drugs and how we treat.
Pardanani A; Reichard K; Tefferi A
Br J Haematol; 2024 Feb; 204(2):402-414. PubMed ID: 38054381
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.
Sotlar K; Cerny-Reiterer S; Petat-Dutter K; Hessel H; Berezowska S; Müllauer L; Valent P; Horny HP
Mod Pathol; 2011 Apr; 24(4):585-95. PubMed ID: 21186345
[TBL] [Abstract][Full Text] [Related]
17. ["Smoldering systemic mastocytosis. "Successful therapy with cladribine].
Schleyer V; Meyer S; Landthaler M; Szeimies RM
Hautarzt; 2004 Jul; 55(7):658-62. PubMed ID: 15241520
[TBL] [Abstract][Full Text] [Related]
18. Systemic mastocytosis--a systematic review.
Andersen CL; Kristensen TK; Severinsen MT; Møller MB; Vestergaard H; Bergmann OJ; Hasselbalch HC; Bjerrum OW
Dan Med J; 2012 Mar; 59(3):A4397. PubMed ID: 22381091
[TBL] [Abstract][Full Text] [Related]
19. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
Horny HP; Sotlar K; Valent P
Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
[TBL] [Abstract][Full Text] [Related]
20. The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD).
Valent P; Arock M; Akin C; Sperr WR; Reiter A; Sotlar K; Hartmann K; George TI; Brockow K; Kluin-Nelemans HC; Gotlib J; Metcalfe DD; Horny HP
Blood; 2010 Aug; 116(5):850-1. PubMed ID: 20688965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
